Search results
Results from the WOW.Com Content Network
The European Patent Office declared a contested mRNA patent owned by Moderna invalid, the office said on Tuesday, handing a win to BioNTech and its partner Pfizer in a patent dispute between the ...
In various patent logs, it is recorded Tesla applied for US patent #613819 for "Filings Tube" (such as Charles Henry Sewall's "Wireless Telegraphy" (New York, 1904)) but it does not seem to have been issued. [7] [8] The Nikola Tesla Museum in Belgrade archives have Tesla prepared material and drawings for patents that he never registered. [7]
Amid the fight over vaccine technology, the companies clashed in court over the interpretation of Moderna’s previous “pledge” not to enforce its Covid-19 related patents while the pandemic ...
(Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech.
The patents cited by various social media posts reference existing patents for genetic sequences and vaccines for other strains of coronavirus such as the SARS coronavirus. [ 117 ] [ 118 ] The WHO reported that as of 5 February 2020, despite news reports of "breakthrough drugs" being discovered, there were no treatments known to be effective ...
All RMPs for COVID‑19 vaccines will be published on the EMA's website. [136] The EMA published guidance for developers of potential COVID‑19 vaccines on the clinical evidence to include in marketing authorization applications. [137] In November 2020, the CHMP started a rolling review of the Moderna vaccine for COVID‑19 known as mRNA-1273 ...
The High Court gave a mixed ruling in July, ruling that one of Moderna's two patents relating to the messenger RNA (mRNA) technology that underpinned its COVID-19 vaccine was invalid.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).